JW Holdings Corporation (KOSE:A096760) acquired an additional 20% stake in JW Life Science Co. Ltd for KRW 28.8 billion on June 1, 2015. Under the terms of the agreement, JW Holdings Corporation acquired 1.6 million shares at KRW 0.018 million per share in JW Life Science Co. Ltd. JW Life Science Co. Ltd reported total assets of ¥160.92 billion, sales of ¥109.55 billion and net profit of ¥7.89 billion for the period ending December 31, 2014.

JW Holdings Corporation (KOSE:A096760) completed the acquisition of an additional 20% stake in JW Life Science Co. Ltd on June 1, 2015.